Wegovy gets FDA approval to reduce risk of heart issues in overweight adults
[ad_1] The FDA on Friday said it approved Novo Nordisk’s popular weight-loss drug Wegovy to reduce the risk of severe heart issues in overweight or
‘I’m very sad’: My brother refinanced our mother’s house and sold the contents. Can we claim a share of the proceeds?
[ad_1] “I wrote him a check for $5,000 15 years ago because my mother would have died on the spot if she had been evicted
I used my RMD to give to charity but my accountant says I messed up and have to pay a penalty
[ad_1] There are some rules you must follow when using a QCD [ad_2] Source link
CDs, I-bonds and TIPS: ‘Guaranteed’ investments may not be worth it
[ad_1] Certainty may be comforting, but you’ll pay the price [ad_2] Source link
Office-to-residential conversions are facing obstacles under White House program, developers say
[ad_1] Property owners say time is running out as the real-estate industry’s finances grow more dire, and claim the federal government needs to remove funding
Amazon CEO Andy Jassy’s $9 million stock sale this week may be cause for caution
[ad_1] Recent transactions by both Amazon’s chief executive and a board member seem linked to the stock’s price, says an expert. [ad_2] Source link
GE draws upgrade to outperform at JPMorgan, ahead of its split into two companies
[ad_1] The industrial giant was praised as a “premium large-cap name” in commercial aerospace. [ad_2] Source link
SoFi’s stock had a historic drop earlier this week. What if it was misguided?
[ad_1] SoFi’s bid to raise capital sparked a record one-day selloff in its shares earlier this week. One analyst thinks Wall Street may have misunderstood
Nvidia’s stock heads for dramatic reverse lower not seen in over two years
[ad_1] Nvidia’s stock has been nearly invincible lately and initially seemed on track to log its seventh session in a row of gains — before
Eli Lilly’s stock dips as Alzheimer’s drug delayed by surprise FDA panel meeting
[ad_1] The FDA is seeking to further understand topics related to evaluating the safety and efficacy of the drug, including results in patients who have